Moderna, Inc.
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna BARDA grant revenue by Quarter
BARDA grant revenue (mRNA-1273 & pandemic influenza) ($M) ($M)
Moderna BARDA grant revenue: $0M in Q4 2023, down 100.0% from a year earlier. No newer figure appears in the documents we track.
Where the Q4 2023 figure comes from
Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)
Source: Form 10-K (filed 2026-02-20) ↗
Reported in Form 10-Q / 10-K Note 3 (Grant Revenue).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | BARDA grant revenue (mRNA-1273 & pandemic influenza) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2023 | Dec 31, 2023 | 0 | -100.0% | Form 10-K (filed 2026-02-20) ↗ |
| Q3 2023 | Sep 30, 2023 | 44 | -68.8% | Form 10-Q (filed 2023-11-03) ↗ |
| Q2 2023 | Jun 30, 2023 | 24 | -86.6% | Form 10-Q (filed 2023-08-03) ↗ |
| Q1 2023 | Mar 31, 2023 | 20 | -83.6% | Form 10-Q (filed 2023-05-04) ↗ |
| Q4 2022 | Dec 31, 2022 | -70 | -127.0% | Form 10-K (filed 2025-02-21) ↗ |
| Q3 2022 | Sep 30, 2022 | 141 | +10.2% | Form 10-Q (filed 2023-11-03) ↗ |
| Q2 2022 | Jun 30, 2022 | 179 | +33.6% | Form 10-Q (filed 2023-08-03) ↗ |
| Q1 2022 | Mar 31, 2022 | 122 | -36.5% | Form 10-Q (filed 2023-05-04) ↗ |
| Q4 2021 | Dec 31, 2021 | 259 | -23.6% | Form 10-K (filed 2024-02-23) ↗ |
| Q3 2021 | Sep 30, 2021 | 128 | -10.5% | Form 10-Q (filed 2022-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 134 | +262.2% | Form 10-Q (filed 2022-08-03) ↗ |
| Q1 2021 | Mar 31, 2021 | 192 | +6,300.0% | Form 10-Q (filed 2022-05-04) ↗ |
| Q4 2020 | Dec 31, 2020 | 339 | +9,585.7% | Form 10-K (filed 2023-02-24) ↗ |
| Q3 2020 | Sep 30, 2020 | 143 | +12,900.0% | Form 10-Q (filed 2021-11-04) ↗ |
| Q2 2020 | Jun 30, 2020 | 37 | +1,847.4% | Form 10-Q (filed 2021-08-05) ↗ |
| Q1 2020 | Mar 31, 2020 | 3 | +100.0% | Form 10-Q (filed 2021-05-06) ↗ |
| Q4 2019 | Dec 31, 2019 | 3.50 | +66.7% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2019 | Sep 30, 2019 | 1.10 | -45.0% | Form 10-Q (filed 2020-10-30) ↗ |
| Q2 2019 | Jun 30, 2019 | 1.90 | +18.7% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 1.50 | +50.0% | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2018 | Dec 31, 2018 | 2.10 | – | Form 10-K (filed 2021-02-26) ↗ |
| Q3 2018 | Sep 30, 2018 | 2 | – | Form 10-Q (filed 2019-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 1.60 | – | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2018 | Mar 31, 2018 | 1 | – | Form 10-Q (filed 2019-05-09) ↗ |
Cite this data
StockData. (2026). Moderna BARDA grant revenue ($M), quarterly Q1 2018–Q4 2023 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/rev-grant-barda
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.